What is Microbot Medical's stock-based comp?

Microbot Medical (MBOT) reported stock-based comp of -2% in Q4 2025.

What does stock-based comp mean?

Measures the impact of non-deductible share-based compensation on the effective tax rate as a percentage of pre-tax income. It provides insight into the tax inefficiency created by equity compensation structures.

Microbot Medical MBOT Stock-Based Comp

Stock-Based Comp at other companies

TFX

TeleflexTFX

16.5%+10.9pp

Other financials

Income statement

See full

Revenue$105.0K—

Gross profit$2.0K—

Operating income-$4.3M-43.0%

Net income-$3.7M-41.1%

EPS (diluted)-$0.05+37.5%

Balance sheet

See full

Cash & equivalents$3.7M+13.7%

Total debt$898.0K+551%

Total equity$74.1M+156%

Total assets$78.1M+153%

Cash flow

See full

Operating cash flow-$5.1M-75.8%

CapEx$108.0K+731%

Free cash flow-$5.2M-78.8%

Valuation

See full

Market cap$128.28M+36.1%

Enterprise value$125.53M+39.0%

P/S674.3×—

Profitability

See full

Operating margin25,292.9%—

Net margin-3,669.9%—

FCF margin-852.8%—

Returns & leverage

See full

Return on equity-27.6%-10.2pp

Debt / equity0×0.0×

Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost.

The official record: Microbot Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Microbot Medical's stock-based comp?: Microbot Medical (MBOT) reported stock-based comp of -2% in Q4 2025.
What does stock-based comp mean?: Measures the impact of non-deductible share-based compensation on the effective tax rate as a percentage of pre-tax income. It provides insight into the tax inefficiency created by equity compensation structures.